One approach is to wait until we have specific therapy related to these genetic risk variants before recommending genetic testing. This is likely to require many years, as drug therapy as a rule could require a minimum of 10 years for development and approval. Another approach would be to incorporate them as risk factors into the current prevention-recommended guidelines. For example, current guid


Who Upvoted this Story